Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer. 2009

Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
Department of Pathology, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan. pathola@med.yokohama-cu.ac.jp

The cancer stem cell (CSC) theory is currently central to the field of cancer research, because it is not only a matter of academic interest but also crucial in cancer therapy. CSCs share a variety of biological properties with normal somatic stem cells in terms of self-renewal, the propagation of differentiated progeny, the expression of specific cell markers and stem cell genes, and the utilization of common signaling pathways and the stem cell niche. However, CSCs differ from normal stem cells in their tumorigenic activity. Thus, CSCs are also termed cancer initiating cells. In this paper, we briefly review hitherto described study results and refer to some excellent review articles to understand the basic properties of CSCs. In addition, we focus upon CSCs of lung cancers, since lung cancer is still increasing in incidence worldwide and remains the leading cause of cancer deaths. Understanding the properties of, and exploring cell markers and signaling pathways specific to, CSCs of lung cancers, will lead to progress in therapy, intervention, and improvement of the prognosis of patients with lung cancer. In the near future, the evaluation of CSCs may be a routine part of practical diagnostic pathology.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation
D014411 Neoplastic Stem Cells Highly proliferative, self-renewing, and colony-forming stem cells which give rise to NEOPLASMS. Cancer Stem Cells,Colony-Forming Units, Neoplastic,Stem Cells, Neoplastic,Tumor Stem Cells,Neoplastic Colony-Forming Units,Tumor Initiating Cells,Cancer Stem Cell,Cell, Cancer Stem,Cell, Neoplastic Stem,Cell, Tumor Initiating,Cell, Tumor Stem,Cells, Cancer Stem,Cells, Neoplastic Stem,Cells, Tumor Initiating,Cells, Tumor Stem,Colony Forming Units, Neoplastic,Colony-Forming Unit, Neoplastic,Initiating Cell, Tumor,Initiating Cells, Tumor,Neoplastic Colony Forming Units,Neoplastic Colony-Forming Unit,Neoplastic Stem Cell,Stem Cell, Cancer,Stem Cell, Neoplastic,Stem Cell, Tumor,Stem Cells, Cancer,Stem Cells, Tumor,Tumor Initiating Cell,Tumor Stem Cell,Unit, Neoplastic Colony-Forming,Units, Neoplastic Colony-Forming
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D055153 Stem Cell Niche A particular zone of tissue composed of a specialized microenvironment where stem cells are retained in a undifferentiated, self-renewable state. Stem Cell Microenvironment,Cell Microenvironment, Stem,Cell Microenvironments, Stem,Cell Niche, Stem,Cell Niches, Stem,Microenvironment, Stem Cell,Microenvironments, Stem Cell,Niche, Stem Cell,Niches, Stem Cell,Stem Cell Microenvironments,Stem Cell Niches
D055752 Small Cell Lung Carcinoma A form of highly malignant lung cancer that is composed of small ovoid cells (SMALL CELL CARCINOMA). Oat Cell Carcinoma of Lung,Carcinoma, Small Cell Lung,Oat Cell Lung Cancer,Small Cell Cancer Of The Lung,Small Cell Lung Cancer

Related Publications

Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
August 1983, Gan no rinsho. Japan journal of cancer clinics,
Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
January 1977, Kyobu geka. The Japanese journal of thoracic surgery,
Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
July 2023, International journal of molecular sciences,
Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
July 1968, Ugeskrift for laeger,
Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
September 2012, Asia-Pacific journal of clinical oncology,
Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
November 2007, Cancer biology & therapy,
Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
January 1955, Schweizerische Zeitschrift fur Pathologie und Bakteriologie. Revue suisse de pathologie et de bacteriologie,
Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
May 1966, Gan no rinsho. Japan journal of cancer clinics,
Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
March 1952, A.M.A. archives of industrial hygiene and occupational medicine,
Hitoshi Kitamura, and Koji Okudela, and Takuya Yazawa, and Hanako Sato, and Hiroaki Shimoyamada
January 1995, Critical reviews in clinical laboratory sciences,
Copied contents to your clipboard!